Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise as nonsteroidal treatments for hair loss.

Compound 4 is a promising treatment for hair loss with low toxicity.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Researchers created a new, efficient way to make Dutasteride, a hair loss and prostate drug, with high purity using a benzoyl group.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

A new, less toxic and more efficient method to create the anti-baldness compound RU58841 was developed in 2014.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Cerasus serrulata flower extracts can help turn grey hair black again.

Monocyclic aromatic compounds are important for developing various drugs and treatments.

Both drugs lower DHT levels, with GI198745 being more effective.

New tests detect finasteride and dutasteride in urine quickly and easily.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.